If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
MURRIETA, CA–Dec 2, 2008 — CLX Clinical, Inc. (OTC BB:CLXN.OB ), which is focused on the marketing and distribution of unique pharma diagnostic testing products, today announced the close of the company’s acquisition of ThyroTest®, a rapid thyroid st…
Diagnostics, Acquisitions
CLX Clinical, ThyroTec, ThyroTest, thyroid stimulating hormone
Posts on ‘December 2nd, 2008’
CLX Medical, Inc. Announces Close of ThyroTest(R) Acquisition
Cubist Names Santosh J. Vetticaden as SVP, Clinical Development and Chief Clinical laboratory Officer
Lexington, MA, December 2nd, 2008 –(HSMN NewsFeed)–Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that Santosh J. Vetticaden, M.D., Ph.D., has joined the company as Senior Vice President, Clinical Development and Chief Clinical Officer. Dr. V…
Biopharmaceuticals, Personnel
Cubist Pharmaceuticals
Caroline Loewy Joins Corcept as Chief Financial Officer
MENLO PARK, CA–Dec TWO, 2008 — Corcept Therapeutics (NasdaqCM:CORT ) today announced the appointment of Caroline M. Loewy to the job of Chief Financial Officer. She will oversee Corcept’s financial operations, business development activities, investor…
Biopharmaceuticals, Personnel
Corcept Therapeutics
TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Medical Trial in Patients with Xerostomia
LA JOLLA, Calif., Dec. 2 (HSMN NewsFeed) — TorreyPines Therapeutics, Inc. (Nasdaq: TPTX ) today announced positive results from a 26 patient Phase II trial evaluating three doses of NGX267 as a treatment for xerostomia, or dry mouth, in patients with Sj…
Biopharmaceuticals
TorreyPines Therapeutics, NGX267, xerostomia, Sjogren’s syndrome
